Dental Care Clinics in Coeur Dalene, ID Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Kootenai Family Dental, Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 1420 Lincoln Way, Suite 200, Coeur Dalene, ID 83814 Phone: 208-664-8283 Fax: 208-667-0794 |
News Archive
Microparticles in crab, shrimp and lobster shells may help prevent inflammatory bowel disease
Yoshimi Shibata, Ph.D., professor of biomedical science in the Charles E. Schmidt College of Medicine at Florida Atlantic University, has received a $380,552 grant from the National Institute of Complementary and Alternative Medicine of the National Institutes of Health to further investigate how microparticles called "chitin" found in crab, shrimp and lobster shells have anti-inflammatory mechanisms that could lead to the development of novel preventive and therapeutic strategies for individuals who suffer from inflammatory bowel disease (IBD) and others diseases.
15.7% of North Carolina women receive delayed or no prenatal care
In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in the United States from pregnancy-related complications, with half of these deaths believed preventable, according to the Centers for Disease Control. A state-by-state examination shows that North Carolina is 37th on a maternal mortality ranking, with 11.4 deaths per 100,000 live births.
New study compares general measures of self-control with domain-specific measures
Whether it's resisting buying a candy bar in the checkout lane or purchasing an unneeded pair of shoes on sale at the mall, self-control varies from person to person. Researchers must pay attention to these differences in individuals' self-control when assessing the impact of public policies, according to a new study by marketing and consumer behavior experts at Rice University and Vanderbilt University.
Ambit Biosciences presents data evaluating FLT3 inhibitor in AML at the 51st ASH meeting
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
› Verified 7 days ago